Earl Martin Douglas, SVP, General Counsel at Allogene Therapeutics, sold ALLO on Aug 21, 2026
Data as of Oct 27
▼ SELL$63K29,697 shares at $2.12Earl Martin Douglas SVP, General CounselALLO Allogene Therapeutics, Inc.
- Traded
- Aug 21, 2026
- Disclosed
- Aug 25, 2026
- Filed
- 4 days after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
ALLO since disclosure
−43.3%
after the sale
Similar stocks (XLV) since disclosure
+2.2%
XLV — its sector index fund
Change in closing price from Aug 25, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.